- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Diaceutics PLC (DXRX)
Diaceutics PLC stock price live, this page displays LON DXRX stock exchange data. View the DXRX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Diaceutics PLC real time stock price chart below.
What Is the Diaceutics PLC Stock Price Today?
The Diaceutics PLC stock price today is 166.00.
What Is the Stock Symbol for Diaceutics PLC?
The stock symbol for Diaceutics PLC is "DXRX."
What Stock Exchange Does Diaceutics PLC Trade On?
Diaceutics PLC is listed and trades on the London stock exchange.
Is Diaceutics PLC a Good Stock to Buy?
Determining whether Diaceutics PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DXRX quote. (ISIN: GB00BJQTGV64)
What Is the Diaceutics PLC Stock Price Today?
The Diaceutics PLC stock price today is 166.00.
What Is the Stock Symbol for Diaceutics PLC?
The stock symbol for Diaceutics PLC is "DXRX."
What Stock Exchange Does Diaceutics PLC Trade On?
Diaceutics PLC is listed and trades on the London stock exchange.
Is Diaceutics PLC a Good Stock to Buy?
Determining whether Diaceutics PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DXRX quote. (ISIN: GB00BJQTGV64)
London
Currency in GBP
166.00
-2.00(-1.19%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
166.00
169.00
52 wk Range
106.00
176.25
Unusual trading volume
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
166.00169.00
52 wk Range
106.00176.25
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
DXRX Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
220.60
Upside
+32.89%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Liquid assets exceed short term obligations
- Diaceutics Plc receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Diaceutics receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Diaceutics Plc receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Diaceutics receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Strong Buy
Diaceutics PLC Company Profile
Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies. The company offers DXRX, a diagnostic commercialization platform for precision medicine that integrates multiple pipelines of diagnostic testing data from a network of laboratories. It also provides DXRX data solutions, including DXRX Signal, which delivers an actionable alert of a testing behavior for making treatment decisions; DXRX Physician Mapping that examines physician testing behavior using patient level data to determine testing rates, methodology, and physician to lab relationship; DXRX Lab Mapping that offers insights into labs currently testing patients diagnosed with a specific disease or biomarker; and DXRX Disease Testing Rate Tracker, which delivers biomarker testing rate reports. In addition, the company offers professional services, such as market landscape, implementation, and consulting services. It operates in North America, the United Kingdom, Europe, Asia, and internationally. The company was incorporated in 2005 and is headquartered in Belfast, the United Kingdom.
Compare DXRX to Peers and Sector
Metrics to compare | DXRX | Sector Sector - Average of metrics from a broad group of related Industrials sector companies | Relationship RelationshipDXRXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −92.7x | −3.8x | −0.5x | |
PEG Ratio | −1.29 | −0.10 | 0.00 | |
Price/Book | 3.8x | 2.3x | 2.6x | |
Price / LTM Sales | 4.1x | 6.5x | 3.3x | |
Upside (Analyst Target) | 35.5% | 58.7% | 45.7% | |
Fair Value Upside | Unlock | 5.7% | 6.5% | Unlock |
Analyst Ratings
5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 220.60
(+32.89% Upside)
Earnings
Latest Release
Jan 15, 2026
EPS / Forecast
0.031 / 0.0447
Revenue / Forecast
24.00M / 24.49M
People Also Watch
FAQ
What Is the Diaceutics (DXRX) Stock Price Today?
The Diaceutics stock price today is 166.00
What Stock Exchange Does Diaceutics Trade On?
Diaceutics is listed and trades on the London Stock Exchange.
What Is the Stock Symbol for Diaceutics?
The stock symbol for Diaceutics is "DXRX."
What Is the Diaceutics Market Cap?
As of today, Diaceutics market cap is 140.96M.
What Is Diaceutics's Earnings Per Share (TTM)?
The Diaceutics EPS (TTM) is -0.02.
When Is the Next Diaceutics Earnings Date?
Diaceutics will release its next earnings report on Mar 23, 2026.
From a Technical Analysis Perspective, Is DXRX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Diaceutics Stock Split?
Diaceutics has split 0 times.
How Many Employees Does Diaceutics Have?
Diaceutics has 213 employees.
What is the current trading status of Diaceutics (DXRX)?
As of Feb 07, 2026, Diaceutics (DXRX) is trading at a price of 166.00, with a previous close of 168.00. The stock has fluctuated within a day range of 166.00 to 169.00, while its 52-week range spans from 106.00 to 176.25.
What Is Diaceutics (DXRX) Price Target According to Analysts?
The average 12-month price target for Diaceutics is GBP220.60, with a high estimate of GBP243 and a low estimate of GBP185. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +32.89% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.